Staff ScientistNational Cancer Institute, Center for Cancer Research, National Institutes of HealthBethesda, Maryland, United States
Disclosure information not submitted.
Immunological targeting of the endogenous retroviral protein ERVMER34-1 in carcinomas promotes epitope spread and enhances response to PD-L1 blockade
Saturday, April 18, 20261:15 PM - 1:30 PM US ET